INJECTABLE BIODEGRADABLE PARTICLES

• US 20090117033A1
• Filed: 10/31/2008
• Published: 05/07/2009
• Est. Priority Date: 11/01/2007
• Status: Active Grant

• Current Assignee: Boston Scientific Scimed (Boston Scientific Corporation)
• Original Assignee: Boston Scientific Scimed (Boston Scientific Corporation)
• Inventors: O'Gara, John E.
• Granted Patent: US 8,246,998 B2
• Time in Patent Office: Days
• US Class Current: 424/1.110
• CPC Class Codes: A61K 47/34 Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers A61K47/10 takes precedence
• CPC Class Codes: A61K 51/1255 Granulates, agglomerates, microspheres
• CPC Class Codes: A61K 9/0024 Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue compositions for intravenous administration, normal injectable solutions or dispersions for, e.g. subcutaneous administration A61K9/0019; brain implants A61K9/0085; (coated) prostheses, catheters or stents A61L
• CPC Class Codes: A61P 43/00 Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
• CPC Class Codes: A61P 9/00 Drugs for disorders of the cardiovascular system
• CPC Class Codes: Y10T 428/2982 Particulate matter [e.g., sphere, flake, etc.]

Abstract

According to an aspect of the invention, injectable polymeric particles are provided that contain a copolymer that contains a hydroxy-acid-based repeat unit selected from a mono(hydroxy acid) unit and a poly(hydroxy acid) unit, an alkyl-ether-based repeat unit selected from a mono(alkyl ether) unit and a poly(alkyl ether) unit, and an acid-based repeat unit selected from a unit comprising multiple carboxylic acid groups and a derivative thereof Other aspects of the invention pertain to methods of making such particles. Still other aspects of the invention pertain to injectable compositions that comprise such particles and to methods of treatment that employ such injectable compositions.

Claims

1. Injectable polymeric particles comprising a copolymer that comprises

(a) a hydroxy-acid-based repeat unit selected from a mono(hydroxy acid) unit and a poly(hydroxy acid) unit,

(b) an alkyl-ether-based repeat unit selected from a mono(alkyl ether) unit and a poly(alkyl ether) unit, and

(c) an acid-based repeat unit selected from a unit comprising multiple carboxylic acid groups, a unit comprising multiple acid chloride groups, and a cyclic acid anhydride unit, wherein 95 vol % of the particles have a longest linear cross-sectional dimension between 40 μ

m and 5000 μ

m.

2. The injectable polymeric particles of claim 1, wherein said alkyl-ether-based repeat unit comprises one or more alkyl ether monomers selected from ethylene oxide, propylene oxide and butylene oxide.

3. The injectable polymeric particles of claim 1, wherein said alkyl-ether-based repeat unit is of the formula 

R₁—

O

_n, where in the preceding formula R₁ is C1-C10 linear or branched alkyl and n is an integer of 1 or more.

4. The injectable polymeric particles of claim 1, wherein said hydroxy-acid-based repeat unit comprises one or more hydroxy acid monomers selected from branched and unbranched C1-C10 hydroxy acids.

5. The injectable polymeric particles of claim 1, wherein said hydroxy-acid-based repeat unit comprises one or more hydroxy acid monomers selected from glycolic acid and lactic acid.

6. The injectable polymeric particles of claim 1, wherein said hydroxy-acid-based repeat unit is of the formula,

where in the preceding formula R₂ is H or C1-C10 linear or branched alkyl and n is an integer of 1 or more.

7. The injectable polymeric particles of claim 1, wherein said acid-based repeat unit is selected from dicarboxylic acids, tricarboxylic acids, dicarboxylic acid chlorides, tricarboxylic acid chlorides, and cyclic acid anhydrides.

8. The injectable polymeric particles of claim 1, wherein said acid-based repeat unit is of the formula,

where in the preceding formula n is one and R₃ is selected from (a) a bond and (b) C1-C10 linear or branched alkyl, which may be either unsubstituted or substituted with one or more halogen atoms.

9. The injectable polymeric particles of claim 8, wherein said one or more halogen atoms comprise bromine atoms, iodine atoms, or a combination thereof.

10. The injectable polymeric particles of claim 1, wherein said particles do not contain an ionic or covalent cross-linking agent.

11. The injectable polymeric particles of claim 1, wherein said copolymer further comprises bromine atoms, iodine atoms or a combination thereof.

12. The injectable polymeric particles of claim 1, wherein said injectable particles are spherical.

13. The injectable polymeric particles of claim 1, wherein said particles are porous particles.

14. The injectable polymeric particles of claim 1, wherein 95 vol % of said particles have a longest linear cross-sectional dimension between 100 and 1200 μ

m.

15. The injectable polymeric particles of claim 1, wherein said copolymer further comprises a group that chelates a charged radioisotope.

16. The injectable polymeric particles of claim 1, further comprising a therapeutic agent selected from toxins, thrombogenic agents, antineoplastic agents, ablation agents, proinflammatory agents and sclerosing agents.

17. The injectable polymeric particles of claim 1, further comprising a therapeutic agent that non-covalently binds to the particles by electrostatic interactions with binding groups in the particles.

18. The injectable polymeric particles of claim 17, wherein said therapeutic agent is a charged radioisotope and said particles comprise ligands that form coordination complexes with the charged radioisotope.

19. The injectable particles of claim 1, wherein said hydroxy-acid-based repeat unit:

alkyl-ether-based repeat unit;

acid-based repeat unit ratio is 1;

1;

1.

20. The injectable particles of claim 1, wherein said hydroxy-acid-based repeat unit:

alkyl-ether-based repeat unit;

acid-based repeat unit ratio is 2;

1;

1.

21. An injectable medical composition comprising the particles of claim 1.

22. The injectable medical composition of claim 21, comprising a tonicity adjusting agent.

23. The injectable medical composition of claim 21, wherein said injectable medical composition is disposed within a glass container or a preloaded medical device.

24. A method of embolization comprising injecting the injectable medical composition of claim 21 into a patient.

25. A method of tissue bulking comprising injecting the injectable medical composition of claim 21 into a patient.